SCHEMBL10272889

SCHEMBL10272889

Bc1cncc(-c2ccc(NS(C)(=O)=O)cc2C)c1OCCOC

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 19/20 0.51
KIT P10721 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10272890 0.89 CYP17A1 (0.54) CYP17A1
SCHEMBL527271 0.88 CYP17A1 (0.50) CYP17A1KIT
SCHEMBL10272891 0.88 CYP17A1 (0.54) CYP17A1
SCHEMBL10272892 0.84 CYP17A1 (0.69) CYP17A1
SCHEMBL10273697 0.81 CYP17A1 (0.72) CYP17A1KIT
SCHEMBL527548 0.77 CYP17A1 (0.53) CYP17A1
SCHEMBL526673 0.76 CYP17A1 (0.56) CYP17A1
SCHEMBL10272855 0.76 CYP17A1 (0.56) CYP17A1
SCHEMBL527064 0.76 CYP17A1 (0.48) CYP17A1
SCHEMBL526683 0.76 CYP17A1 (0.53) CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012015723-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-02 WO disclosed